Cumulative 2012/2013 Season Lot Release Status (Updated 3/14/2013)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers. For information on flu vaccine distribution schedules, please contact the manufacturers directly.
|Manufacturer||Total Number of Lots Released by FDA|
ID Biomedical Corp. of Quebec
Novartis Vaccines and Diagnostics Incorporated
Novartis Vaccines and Diagnostics Limited
Sanofi Pasteur, Inc.
|Protein Sciences Corp||4|
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Silver Spring, Maryland, on February 28, 2012, to select the influenza viruses for the composition of the influenza vaccine for the 2012-2013 U.S. influenza season. During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2011-2012 vaccines, and the availability of candidate strains and reagents.
- an A/California/7/2009 (H1N1)-like virus;
- an A/Victoria /361/2011 (H3N2)-like virus;
- a B/Wisconsin /1/2010-like virus.
- a B/Brisbane/60/2008-like virus